Cortex, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cortex, Inc. - overview
Established
2023
Location
Menlo Park, CA, US
Primary Industry
Medical Devices & Equipment
About
Founded in 2023 and based in California, US, Cortex, Inc. operates as a healthcare platform that is developing a solution for atrial fibrillation, allowing for the easy diagnosis of heart rhythm disorders. In December 2023, Cortex raised USD 90 million in venture funding co-led by new investors KKR and Hellman & Friedman, with participation from another new investor AI Life Sciences Investments. Cortex is dedicated to developing a next-generation suite of technologies for Atrial Fibrillation (Afib) evaluation and treatment.
Their goal is to improve clinical outcomes and safety for patients while also simplifying workflows and increasing procedural efficiency. This will be achieved through advanced diagnostic and ablation catheters, along with a comprehensive mapping and navigation solution powered by Ablacon's Electrographic Flow® technology. The company will use the funding to advance its research and development and support innovative technology mapping.
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Therapeutic Devices
Website
www.cortexep.com
Verticals
Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.